skip to main content
Refinado por: Nome da Publicação: Annals Of Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
319PThe role of AXL as mechanism of resistance to trastuzumab and a prognostic factor in breast cancer HER2 positive: A translational approach
Material Type:
Artigo
Adicionar ao Meu Espaço

319PThe role of AXL as mechanism of resistance to trastuzumab and a prognostic factor in breast cancer HER2 positive: A translational approach

Adam-Artigues, A ; Tormo, E ; Rojo, F ; Perez-Fidalgo, J A ; Zazo, S ; Gonzalez-Alonso, P ; Hernando, C ; Martínez, M T ; Gambardella, V ; Poveda, J ; Simón, S ; Moragon, S ; Alonso, E ; Rovira, A ; Albanell, J ; Burgues, O ; Bermejo, B ; Eroles, P ; Lluch, A ; Cejalvo, J M

Annals of oncology, 2019-10, Vol.30 (Supplement_5) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

2
319P - The role of AXL as mechanism of resistance to trastuzumab and a prognostic factor in breast cancer HER2 positive: A translational approach
Material Type:
Artigo
Adicionar ao Meu Espaço

319P - The role of AXL as mechanism of resistance to trastuzumab and a prognostic factor in breast cancer HER2 positive: A translational approach

Adam-Artigues, A. ; Tormo, E. ; Rojo, F. ; Perez-Fidalgo, J.A. ; Zazo, S. ; Gonzalez-Alonso, P. ; Hernando, C. ; Martínez, M.T. ; Gambardella, V. ; Poveda, J. ; Simón, S. ; Moragon, S. ; Alonso, E. ; Albanell, J. ; Burgues, O. ; Bermejo, B. ; Eroles, P. ; Lluch, A. ; Cejalvo, J.M. ; Rovira, A.

Annals of oncology, 2019-10, Vol.30, p.v110-v110 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

3
The role of AXL as mechanism of resistance to trastuzumab and a prognostic factor in breast cancer HER2 positive: A translational approach
Material Type:
Artigo
Adicionar ao Meu Espaço

The role of AXL as mechanism of resistance to trastuzumab and a prognostic factor in breast cancer HER2 positive: A translational approach

Adam-Artigues, A. ; Tormo, E. ; Rojo, F. ; Perez-Fidalgo, J.A. ; Zazo, S. ; Gonzalez-Alonso, P. ; Hernando, C. ; Martínez, M.T. ; Gambardella, V. ; Poveda, J. ; Simón, S. ; Moragon, S. ; Alonso, E. ; Albanell, J. ; Burgues, O. ; Bermejo, B. ; Eroles, P. ; Lluch, A. ; Cejalvo, J.M. ; Rovira, A.

Annals of oncology, 2019-10, Vol.30, p.v110 [Periódico revisado por pares]

Texto completo disponível

4
Anti-tumor activity of PM01183 (lurbinectedin) in BRCA1/2-associated metastatic breast cancer patients: results of a single-agent phase II trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Anti-tumor activity of PM01183 (lurbinectedin) in BRCA1/2-associated metastatic breast cancer patients: results of a single-agent phase II trial

Balmaña, J. ; Cruz, C. ; Arun, B.K. ; Telli, M. ; Garber, J. ; Domchek, S. ; Fernandez, C.M. ; Kahatt, C. ; Szyldergemajn, S. ; Soto-Matos, A. ; Haza, A. Perezdela ; Fidalgo, J.A. Perez ; Lluch-Hernandez, A. ; Antolin, S. ; Tung, N.M. ; Vahdat, L.T. ; Lopez, R. ; Isakoff, S.J.J.

Annals of oncology, 2016-10, Vol.27, p.vi68-vi68 [Periódico revisado por pares]

Elsevier Ltd

Texto completo disponível

5
1278P How do hospitalized patients with chronic liver disease, with and without hepatocellular carcinoma, die? End-of-life quality analysis
Material Type:
Artigo
Adicionar ao Meu Espaço

1278P How do hospitalized patients with chronic liver disease, with and without hepatocellular carcinoma, die? End-of-life quality analysis

Bravo, A.C. ; Nascimento, C.N. ; Abreu, B. ; Revés, J. ; Morão, B. ; Frias-Gomes, C. ; Canhoto, M. ; Glória, L. ; Fidalgo, C.A.

Annals of oncology, 2022-09, Vol.33, p.S1130 [Periódico revisado por pares]

Texto completo disponível

6
285PDBalixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial
Material Type:
Artigo
Adicionar ao Meu Espaço

285PDBalixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial

Cortes Castan, J ; Martín, M ; Pernas Simon, S ; Gomez Pardo, P ; Lopez-Tarruella, S ; Gil Martin, M ; Manso, L M ; Ciruelos, E M ; Perez Fidalgo, J A ; Hernando, C ; Ademuyiwa, F ; Weilbaecher, K ; Mayer, I A ; Pluard, T ; Martinez Garcia, M ; Vahdat, L T ; Wach, A ; Barker, D ; Romagnoli, B ; Kaufman, P A

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

7
Balixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial
Material Type:
Artigo
Adicionar ao Meu Espaço

Balixafortide (a novel CXCR4 inhibitor) and eribulin in HER2-neg metastatic breast cancer (MBC) patients (pts): A phase I trial

Cortes Castan, J. ; Martín, M. ; Pernas Simon, S. ; Gomez Pardo, P. ; Lopez-Tarruella, S. ; Gil Martin, M. ; Manso, L.M. ; Ciruelos, E.M. ; Perez Fidalgo, J.A. ; Hernando, C. ; Ademuyiwa, F. ; Weilbaecher, K. ; Mayer, I.A. ; Pluard, T. ; Martinez Garcia, M. ; Vahdat, L.T. ; Wach, A. ; Barker, D. ; Romagnoli, B. ; Kaufman, P.A.

Annals of oncology, 2018-10, Vol.29, p.viii91-viii92 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

8
Solitary Fibrous Tumor (Sft): a Registry Program to Assess Frequency and Managemente in Our Country. a Spanish Group for Research on Sarcoma (Geis) Study
Material Type:
Artigo
Adicionar ao Meu Espaço

Solitary Fibrous Tumor (Sft): a Registry Program to Assess Frequency and Managemente in Our Country. a Spanish Group for Research on Sarcoma (Geis) Study

Cruz Jurado, J. ; Valverde Morales, C. ; Vaz, M.A. ; Alvarez Alvarez, R. ; Lopez-Pousa, A. ; Sancho Marquez, P. ; Carrasco, J.A. ; Martinez-Trufero, J. ; Sala Gonzalez, M.A. ; Arranz, J.L. ; De Sande González, L.M. ; Blanco Sanchez, M.J. ; Orbegoso, C. ; Pérez-Fidalgo, J.A. ; Martinez García, J. ; Lavernia, J. ; Sevilla, I. ; Cano, J.M. ; Meana, A. ; Martin Broto, J.

Annals of oncology, 2014-09, Vol.25, p.iv507 [Periódico revisado por pares]

Texto completo disponível

9
1453PSOLITARY FIBROUS TUMOR (SFT): A REGISTRY PROGRAM TO ASSESS FREQUENCY AND MANAGEMENTE IN OUR COUNTRY. A SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS) STUDY
Material Type:
Artigo
Adicionar ao Meu Espaço

1453PSOLITARY FIBROUS TUMOR (SFT): A REGISTRY PROGRAM TO ASSESS FREQUENCY AND MANAGEMENTE IN OUR COUNTRY. A SPANISH GROUP FOR RESEARCH ON SARCOMA (GEIS) STUDY

Cruz Jurado, J ; Valverde Morales, C ; Vaz, M.A ; Alvarez Alvarez, R ; Lopez-Pousa, A ; Sancho Marquez, P ; Carrasco, J.A ; Martinez-Trufero, J ; Sala Gonzalez, M.A ; Arranz, J.L ; De Sande González, L.M ; Blanco Sanchez, M.J ; Orbegoso, C ; Pérez-Fidalgo, J.A ; Martinez García, J ; Lavernia, J ; Sevilla, I ; Cano, J.M ; Meana, A ; Martin Broto, J

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv507-iv508 [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

10
1860PCarcinoma of unknown origin: Deep genomic profile helps to achieve an accurate diagnosis
Material Type:
Artigo
Adicionar ao Meu Espaço

1860PCarcinoma of unknown origin: Deep genomic profile helps to achieve an accurate diagnosis

Fernandez Díaz, A B ; Iranzo Gonzalez-Cruz, V ; Cunquero Tomas, A J ; Avila Andrade, C ; Jantus-Lewintre, E ; Calabuig Fariñas, S ; Ales, J E ; Valero, M ; D'Errico, G ; Pazo Cid, R A ; Gallego Martínez, A ; Viana, A ; Ponce Aix, S ; Pérez-Fidalgo, J A ; Terradez, A ; Rodrigo, A ; Alvarez, L ; Beniuga, G ; Martorell, M ; Camps, C

Annals of oncology, 2018-10, Vol.29 (suppl_8) [Periódico revisado por pares]

Oxford University Press

Texto completo disponível

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Buscando em bases de dados remotas. Favor aguardar.